JPRN-UMIN000018372
Completed
Phase 2
A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergy - A pilot study for the effect of jam oral immunotherapy with hypoallergenized cow's milk (JMIT study)
ational Center for Child Health and Development0 sites10 target enrollmentJuly 24, 2015
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- food allergy (cow'
- Sponsor
- ational Center for Child Health and Development
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with non\-immediate reaction to cow's milk 2\. Patients with uncontrolled asthma, atopic dermatitis or urticaria 3\. Patients with pineapple or soy allergy 4\. Patients who have treatment history or plan with omalizumab 5\. Patients who were undergoing oral immunotherapy of build\-up phase for other food antigen
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMajor Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-003359-58-GBCPS Research60
Completed
Not Applicable
Combination therapy of Visudyne, Minocycline, Dexamethasone and Ranibizumab (VIMDER) for the treatment of subfoveal choroidal neovascularisation (CNV)ISRCTN34410935King's College Hospital NHS Foundation Trust (UK)20
Completed
Not Applicable
A pilot study to examine the safety and efficacy of posterior juxta-scleral (80 mg) triamcinolone acetonide, administration, in addition to Visudyne (verteporfin) photodynamic therapy for predominantly classic choroidal neovascularisation secondary to age-related macular degeneration: an open-label, randomised, active controlled trialISRCTN33957677King's College Hospital (UK)80
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucomaISRCTN23263504Transcend Medical, Inc.™ (USA)20
Completed
Not Applicable
Transcend CyPass glaucoma implant and cataract surgery in open angle glaucoma patientsISRCTN86839890Transcend Medical, Inc.™ (USA)20